These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K. Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [Abstract] [Full Text] [Related]
8. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics. Qadri SM, Belobraydic KA. Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346 [Abstract] [Full Text] [Related]
10. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates. Rubinstein E, Mark Z, Samra Y, Alkan M, Berger S. Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966 [Abstract] [Full Text] [Related]
12. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro]. De Rosa F, Tassi C, Stagni GR. Ann Sclavo; 1974 Apr; 16(1):65-72. PubMed ID: 4214247 [No Abstract] [Full Text] [Related]
13. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics. Paradelis AG, Stathopoulos GA, Salpigides GN, Crassaris LG. Methods Find Exp Clin Pharmacol; 1983 Apr; 5(6):375-83. PubMed ID: 6684718 [Abstract] [Full Text] [Related]
14. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). Sader HS, Farrell DJ, Flamm RK, Jones RN. J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763 [Abstract] [Full Text] [Related]
15. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932 [Abstract] [Full Text] [Related]
16. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)]. Deguchi K, Oda S, Sato Y, Ikeda Y, Nakamura T. Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913 [Abstract] [Full Text] [Related]
17. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates. Greenberg RN, Bowne DB, Gelfand M, Sathe SS. Clin Ther; 1990 Dec; 12(1):61-70. PubMed ID: 2183941 [Abstract] [Full Text] [Related]
18. [Susceptibility of clinical isolates to aztreonam]. Asari S, Horikawa M, Tsukamoto H, Kouda K, Hayashi C, Miyai K. Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624 [Abstract] [Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). III. Secular changes in susceptibility]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H. Jpn J Antibiot; 1995 Sep; 48(9):1174-263. PubMed ID: 7474335 [Abstract] [Full Text] [Related]
20. [Statistical observation on chronological changes of sensitivity of various bacteria to antibiotics. 1. Gram negative bacilli; Escherichia coli, Bacillus pneumoniae, Proteus vulgaris, Alcaligenes faecalis, Cloaca, Providencia, Citrobactor, Pseudomonas aeruginosa (1966-71)]. Fukazawa S, Ogi Kayoko Shimoama Y, Shimogaki F, Uete T. Nihon Rinsho; 1973 Feb; 31(2):457-65. PubMed ID: 4198261 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]